Executive perspective

AmerisourceBergen Shares Perspectives on SCOTUS ACA Decision

At AmerisourceBergen, we are united in creating healthier futures and believe in the accessibility and affordability of health and pharmaceutical care. In alignment with that purpose, we’re pleased with today’s Supreme Court Affordable Care Act decision which creates peace of mind for patients everywhere as necessary protections will continue, including essential bans on lifetime benefit caps and restrictions based on pre-existing conditions. In addition, today’s decision effectively preserves the Biologics Price Competition and Innovation Act of 2009 (BPCIA), which enables a critical pathway for Biosimilar therapies to come to market. The preservation of the BPCIA pathway is a win for patient access and pharmaceutical innovation. Biosimilars play an essential role in lowering drug prices across therapeutic categories and expanding patient access to treatments.

Related content

Press release

IntrinsiQ Specialty Solutions Expands Data Capabilities, Empowering Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

October 16, 2025

Learn more

Media statement

Cencora to Support Commercial Launch of Precigen’s Novel Immunotherapy in the United States

September 24, 2025

Learn more

Media mention

ThoughtSpot 2025 Highlights Cencora’s Commitment to Advancing the Future of Pharmacy and Ensuring Medication Access

August 27, 2025

Learn more

Media contacts

Need help or have questions?  Send us a message and we'll get back to you soon.

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.